Dashboard
Manage Tickers

NUWENuwellis, Inc.

Nasdaq nuwellis.com


$ 1.42 $ 0.07 (5.19 %)    

Friday, 30-Aug-2024 14:31:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 1.42
$ 1.37 x 100
-- x --
-- - --
$ 1.17 - $ 92.75
75,158
na
1.96M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-11-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-03-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-05-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-22-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-15-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-20-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nuwellis-announces-publication-of-study-in-current-problems-in-cardiology-demonstrating-the-aquadex-ultrafiltration-therapy-reduced-60-day-hospital-readmission-rates-for-adhf-patients
Nuwellis Announces Publication Of Study In...
08/27/2024 13:02:37

nuwellis-announces-916k-direct-offering-and-private-placement-issuing-496901-shares-at-18450-per-share-and-warrants-for-an-additional-496901-shares-with-a-172-exercise-price
Nuwellis Announces $916K Direct Offering A...
08/23/2024 13:02:49

 Closing Expected On August 26, 2024, With Proceeds To Support Working Capital And Corporate Purposes

nuwellis-files-new-patent-application-titled-extracorporeal-blood-filtering-machine-and-methods-for-renal-replacement-therapy
Nuwellis Files New Patent Application Titl...
08/22/2024 18:30:41

roth-mkm-reiterates-buy-on-nuwellis-maintains-17-price-target
Roth MKM Reiterates Buy on Nuwellis, Maint...
08/13/2024 18:08:49

Roth MKM analyst Jonathan Aschoff reiterates Nuwellis (NASDAQ:NUWE) with a Buy and maintains $17 price target.

nuwellis-q2-2024-gaap-eps-1885-misses-824-estimate-sales-219m-beat-200m-estimate
Nuwellis Q2 2024 GAAP EPS $(18.85) Misses ...
08/13/2024 12:02:30

Nuwellis (NASDAQ:NUWE) reported quarterly losses of $(18.85) per share which missed the analyst consensus estimate of $(8.24) b...

nuwellis-granted-continued-listing-on-the-nasdaq-stock-market-subject-to-conditions
Nuwellis Granted Continued Listing On The ...
08/08/2024 13:02:54

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on transforming the lives of people with fluid overload (the...

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

why-nuwellis-stock-is-climbing
Why Nuwellis Stock Is Climbing
07/29/2024 17:13:50

Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated ...

roth-mkm-initiates-coverage-on-nuwellis-with-buy-rating-announces-price-target-of-17
Roth MKM Initiates Coverage On Nuwellis wi...
07/29/2024 13:59:06

Roth MKM analyst Jonathan Aschoff initiates coverage on Nuwellis (NASDAQ:NUWE) with a Buy rating and announces Price Target ...

Core News & Articles
Nuwellis Announces First Patient Treated W...
07/26/2024 13:01:07

QUELIMMUNE, Manufactured For SeaStar Medical And Licensed By Nuwellis, Targets Pediatric AKI Patients With Sepsis Requiring Kid...

crude-oil-gains-1-att-shares-rise-after-q2-earnings
Crude Oil Gains 1%; AT&T Shares Rise After...
07/24/2024 18:37:16

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

dow-tumbles-300-points-tesla-shares-plunge-after-q2-results
Dow Tumbles 300 Points; Tesla Shares Plung...
07/24/2024 16:30:09

nasdaq-down-2-alphabet-posts-upbeat-earnings
Nasdaq Down 2%; Alphabet Posts Upbeat Earn...
07/24/2024 14:17:19

nuwellis-announces-pricing-of-2m-offering-of-469340-shares-of-common-stock-at-a-price-of-424-per-share-priced-at-the-market-under-nasdaq-rules
Nuwellis Announces Pricing Of $2M Offering...
07/24/2024 12:11:09

Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a medical technology company focused on transformin...

Core News & Articles
Nuwellis Marks First Commercial Sale Of QU...
07/17/2024 13:08:43

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid...

Core News & Articles
SeaStar Medical Announces Initial Commerci...
07/12/2024 12:36:19

nuwellis-presents-clinical-evidence-demonstrating-efficacy-of-aquadex-system-at-heart-failure-society-of-america-annual-scientific-meeting
Nuwellis Presents Clinical Evidence Demons...
07/09/2024 13:02:47

why-mainz-biomed-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket
Why Mainz Biomed Shares Are Trading Higher...
07/09/2024 09:33:25

nuwellis-shares-resume-trade
Nuwellis Shares Resume Trade
07/08/2024 20:00:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION